MMMaurice Michel

Maurice Michel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maurice Michel has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Low Health Literacy in Patients with Steatotic Liver Disease and Depressive Symptoms

    by Leonard Kaps, Christian Labenz, Alexander Barton, Jörn M. Schattenberg, Maurice Michel

    Background and Objectives: Health literacy (HL) affects the course of chronic diseases, yet little is known about HL in steatotic liver disease (SLD), and the role of mental comorbidities has not been examined. This study assessed HL in patients with SLD and sought to identify factors linked to lower HL. Materials and Methods: This bicentric cross-sectional study comprised 234 patients with SLD: 209 recruited prospectively in Homburg, Germany (2024–2025), and 25 patients with metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis from an existing cohort in Mainz. HL was measured with the German version of the nine-scale Health Literacy Questionnaire (HLQ). SLD was defined by a controlled attenuation parameter ≥ 275 dB/m, and advanced chronic liver disease (ACLD) by liver stiffness ≥ 15 kPa (Baveno VII/VIII) or known cirrhosis. Depressive symptoms were assessed with the Patient Health Questionnaire-9 (PHQ-9 ≥ 10; Homburg) or the Hamilton Depression Rating Scale (HDRS-17 ≥ 8; Mainz). Results: Sixty-eight patients (29%) had depressive symptoms (Homburg 25.8%, Mainz 56.0%). The groups were comparable with respect to age, sex, schooling, liver stiffness and BMI. In univariable analyses, patients with depressive symptoms had lower scores on scales 2, 3, 6 and 7. After adjustment for sex, age, BMI, schooling, and ACLD, associations remained significant for scale 2 (“Having sufficient information to manage my health”; β = −0.14, p = 0.04), scale 3 (“Actively managing my health”; β = −0.15, p = 0.02), scale 6 (“Ability to actively engage with healthcare providers”; β = −0.21, p = 0.003) and scale 7 (“Navigating the healthcare system”; β = −0.16, p = 0.02). The association with scale 6 was consistent across all sensitivity analyses, including an analysis restricted to the Homburg cohort. ACLD was not independently associated with any HLQ scale, whereas higher BMI was associated with lower scores in five of nine domains. Conclusions: More than one in four patients with SLD has depressive symptoms, which are associated with lower self-reported HL, especially regarding engagement with healthcare providers and navigation of the healthcare system. Screening for depression could help to identify patients who require additional support.

  • Open Access

    Vitamin (B1, B6, B12, D, and Folate) and Mineral (Iron, Selenium, and Magnesium) Status Across the Spectrum of Severe Obesity: An Integrative Multivariate Analysis of Metabolic and Nutritional Profiles

    by Hannah Sabados, Sandra Möwius, Ute M. Stern, Maurice Michel, Jörn M. Schattenberg, Verena Keller

    Background: Obesity is frequently accompanied by metabolic dysfunction and micronutrient deficiencies, yet data on individuals with severe obesity (BMI ≥ 50 kg/m2) remain limited. Understanding how vitamin and mineral status changes across the adiposity continuum may optimize personalized nutritional management in severe obesity. Methods: We analyzed anthropometric, metabolic, hepatic, and micronutrient parameters in a retrospective, single-center cohort of adults evaluated before bariatric surgery, with a BMI range of 30 to 91 kg/m2 (mean 48.7 ± 8.7). Measurements included bioimpedance-derived body composition, liver elastography (CAP and stiffness), and fasting laboratory parameters, vitamins B1, B6, B12, D, and folate and minerals (iron, selenium, and magnesium). Correlation analysis, principal component analysis (PCA), and random forest (RF) classification were applied to identify the variables most strongly associated with BMI and metabolic phenotypes. Results: Several micronutrient concentrations, most notably vitamin D, folate and vitamin B6, declined progressively with increasing BMI. Vitamin D additionally correlated inversely with HbA1c. PCA revealed a separation of participants with extreme obesity driven by anthropometric and hepatic parameters, while micronutrients clustered inversely. RF classification identified HbA1c, hepatic enzymes (ALAT and γ-GT) and body-composition measures (waist circumference and visceral fat) as the strongest discriminators of T2DM, MASLD and high BMI, respectively. Combined MASLD and T2DM was associated with the most pronounced vitamin B6 depletion, whereas vitamin D was low across metabolic subgroups. Conclusions: Severe obesity is associated with distinct micronutrient depletion patterns that mirror metabolic deterioration. Integrating nutritional and metabolic profiling enables refined risk stratification and may, pending prospective validation, inform targeted supplementation strategies in individuals with severe obesity.

  • Open Access

    A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population Setting

    by Laurens A. van Kleef, Maurice Michel, Mesut Savas, Jesse Pustjens, Roel van de Laar, Edith Koehler, Elisabeth F.C. van Rossum, Harry L.A. Janssen, Jörn M. Schattenberg, Willem P. Brouwer

    INTRODUCTION: Adipose tissue is a key mediator of metabolic dysfunction-associated steatotic liver disease (MASLD) development and progression into metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis. Since direct comparisons of body composition parameters are lacking, we here investigate 12 different body composition parameters. METHODS: Adult participants from National Health and Nutrition Examination Survey 2017–2023 with liver health data were included. Exclusion criteria were age older than 80 years, excessive alcohol (>60 g/d), viral hepatitis, and missing anthropometrics. MASLD was defined as controlled attenuation parameter ≥275 dB/m with metabolic dysfunction, MASH as FibroScan-aspartate aminotransferase ≥0.35, and increased liver stiffness measurement (LSM) as ≥8 kPa. Predictive performance of 12 body composition parameters was assessed using area under the curve analysis. Predicted probabilities of outcomes were visualized for standardized parameters, and nonlinearity was assessed through restricted cubic splines. RESULTS: Among 11,579 participants (age 51 [35–63], 47% male), 41% had MASLD, 6.5% at-risk MASH, and 9.9% increased LSM. Waist circumference (WC) and not BMI or waist-to-height ratio obtained the highest area under the curve for MASLD (0.82), at-risk MASH (0.73), and increased LSM (0.75) outperforming or equaling all other indices across subgroups. Associations between WC and MASLD were nonlinear, with slight risk saturation beyond 100 cm; at-risk MASH was linearly associated across the entire spectrum; and increased LSM risk rose only after WC >100 cm. DISCUSSION: In the general population, MASLD and MASH risk increased even when WC < 100 cm, while increased LSM risk was increasing only >100 cm. Although relatively minor differences, WC consistently demonstrated the highest predictive value for MASLD, at-risk MASH, and increased LSM and therefore most suited for MASLD diagnosis, management, and risk stratification.